Apoptosis and related genes in the rat ventral prostate following androgen ablation in response to ethane dimethanesulfonate

Prostate

Volumn 36, Issue 1, 1998, Pages 23-30

  Woolveridge, Ian ^a   Taylor, Matthew F ^a   Wu, Fred C W ^a   Morris, Ian D ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Bax; Bcl 2; Bcl xl; EDS; Fas; p53

Indexed keywords

ANDROGEN; ETHYLENE GLYCOL DIMESYLATE; FAS ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; TESTOSTERONE;

ANDROGEN RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HORMONE INHIBITION; IMMUNOBLOTTING; MALE; NONHUMAN; ONCOGENE; ORGAN WEIGHT; PRIORITY JOURNAL; PROSTATE VENTRAL LOBE; PROTEIN EXPRESSION; RAT;

ANDROGENS; ANIMALS; ANTIGENS, CD95; APOPTOSIS; CLUSTERIN; GENE EXPRESSION REGULATION; GENES, BCL-2; GENES, P53; GLYCOPROTEINS; MALE; MESYLATES; MOLECULAR CHAPERONES; ORGAN SIZE; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; SECRETORY RATE;

EID: 0032526595     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980615)36:1<23::AID-PROS4>3.0.CO;2-C     Document Type: Article

References (54)

1. Sanford NL, Searle JW, Kerr JFR: Successive waves of apoptosis in the rat prostate after repeated withdrawal of testosterone. Pathology 1984;16:406-410.
2. Banerjee PP, Banerjee S, Tilly KI, Tilly JL, Brown TR, Zirkin BR: Lobe-specific apoptotic cell death in rat prostate after androgen ablation by castration. Endocrinology 1995;136:4368-4376.
3. Montpetit ML, Lawless KR, Tenniswood M: Androgen repressed messages in the rat ventral prostate. Prostate 1986;8:25-36.
4. Kyprianou N, Isaacs JT: Expression of TGF-β in the rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 1989;3:1515-1522.
5. 1 mRNA as the androgen-repressed mRNA by cDNA cloning and sequence analysis. J Biol Chem 1987;262:11901-11903.
6. Buttyan R, Zakeri Z, Lockshin R, Wolgemuth D: Cascade induction of c-fos, c-myc, and heat shock 70K transcripts during regression of the rat ventral prostate gland. Mol Endocrinol 1988; 2:650-657.
7. Guenette RS, Daehlin L, Mooibroek M, Wong K, Tenniswood M: Thanatogen expression during involution of the rat ventral prostate after castration. J Androl 1994;15:299-211.
8. Vaux DL, Cory S, Adams TM: Bcl-2 promotes the survival of haemopoietic cells and co-operates with c-myc to immortalize pre-B cells. Nature 1988;335:440-442.
9. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson C: Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic death. Cell 1993;74:597-608.
10. Oltavi ZN, Millman CL, Korsmeyer SJ: Bcl-2 heterodimers in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-619.
11. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC: Tumor suppresser p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994;9:1799-1805.
12. Owen-Schaub L, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, Roth JA, Deisseroth AB, Zhang W-W, Kruzel E, Radinsky R: Wild-type human p53 and a temperature sensitive mutant induce Fas/Apo-1 expression. Mol Cell Biol 1995;15: 3032-3040.
13. Suda T, Nagata S: Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 1994;179:873-879.
14. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S-I, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-243.
15. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Ponstingl H, Krammer PH: Purification and molecular cloning of the APO-I cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J Biol Chem 1992;267: 10709-10715.
16. French LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, Muller C, Tschopp J: Fas and fas ligand in embryos and adult mice-ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol 1996;133:335-343.
17. Takeuchi T, Sasaki Y, Ueki T, Kaziwara T, Moriyama N, Kawabe K, Kakizoe T: Modulation of growth and apoptosis response in PC-3 and LNCAP prostate-cancer cell lines by Fas. Int J Cancer 1996;67:709-714.
18. Suzuki A, Matsuzawa A, Iguchi T: Down regulation of Bcl-2 is the first step on fas-mediated apoptosis of male reproductive tract. Oncogens 1996;13:31-37.
19. 125I-labeled hCG, light and electron microscopy of the repopulation of rat Leydig cells after destruction due to administration of ethylene-1,2-dimethanesulphonate. J Reprod Fertil 1986;76:1-10.
20. Morris ID: Leydig cell toxicology. In Payne AH, Hardy MP, Russell LD (eds): ″The Leydig Cell,″ Vienna, IL: Cache River Press, 1996:573-596.
21. Morris AJ, Taylor MF, Morris ID: Leydig cell apoptosis in response to ethane dimethanesulphonate after both in vivo and in vitro treatment. J Androl 1997;18:274-280.
22. Kelce WR, Zirkin BR: Mechanism by which ethane dimethane-sulphonate kills adult rat Leydig cells: Involvement of intracellular glutathione. Toxicol Appl Pharmacol 1993;120:80-88.
23. Morris ID, Phillips DM, Bardin CW: Ethylene dimethanesulfonate destroys Leydig cells in the rat testis. Endocrinology 1986; 118:709-719.
24. Kerr JB, Bartlett JMS, Donnachie K, Sharpe RM: Origin of regenerating Leydig cells in the testis of the adult rat. An ultrastructural, morphometric and hormonal assay study. Cell Tissue Res 1987;249:367-377.
25. Molenaar R, de Rooij DG, Rommerts FFG, Reuvers PJ, van der Molen HJ: Specific destruction of Leydig cells in mature rats after in vivo administration of ethane dimethyl sulfonate. Biol Reprod 1985;33:1213-1222.
26. Tena-Sempere M, Pinilla L, Aguilar E: Follicle-stimulating hormone and luteinizing hormone secretion in male rats orchidectomised or injected with ethylene dimethane sulphonate. Endocrinology 1993;133:1173-1181.
27. Jackson CM, Jackson H: Comparative protective actions of gonadotrophins and testosterone against the antispermatogenic action of ethane dimethanesulphonate. J Reprod Fertil 1984;71: 393-401.
28. Taylor MF, Woolveridge I, Metcalfe A, Streuli CH, Hickman JA, Morris ID: Leydig cell apoptosis in the rat testes after the cytotoxin ethane dimethanesulphonate: Role of the Bcl-2 family members. J Endocrinol 1998; in press.
29. Maniatis T, Fritsch EF, Sambrook J: ″Molecular Cloning. A Laboratory Manual,″ Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1982.
30. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
31. Bradford MM: A rapid and sensitive method for the quantification of microgram quantities of protein using the principal of protein dye binding. Anal Biochem 1976;72:248-254.
32. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
33. Lee C: Physiology of castration-induced regression in rat prostate. Prog Clin Biol Res 1981;75:145-159.
34. Isaacs JT: Antagonistic effects of androgen on prostatic cell death. Prostate 1984;5:545-558.
35. English HF, Santen RJ, Isaacs JT: Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 1987;11:229-242.
36. English HF, Kyprianou N, Isaacs JT: Relationship between DNA fragmentation and apoptosis in the programmed cell death of the rat ventral prostate. Prostate 1989;15:233-250.
37. Kyprianou N, Isaacs JT: Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 1988;122: 552-562.
38. Bruchovsky N, Lesser B, Van Doom E, Craven S: Hormonal effects on cell proliferation in rat prostate. Vitam Horm Res 1975;33:61-100.
39. Kyprianou N, English HF, Isaacs JT: Activation of Ca2+/Mg2+-dependent endonuclease as an early event in castration-induced prostatic cell death. Prostate 1989;13:103-118.
40. Griswold MD, Roberts K, Bishop P: Purification and characterization of a sulfated glycoprotein secreted by Sertoli cell. Biochemistry 1986;25:7265-7270.
41. Ahuja HS, Tenniswood M, Lockshin R, Zakeri ZF: Expression of clusterin in cell differentiation and cell death. Biochem Cell Biol 1994;72:523-530.
42. Leger JG, Montpetit ML, Tenniswood MP: Characterization and cloning of androgen-repressed mRNAs from rat ventral prostate. Biochem Biophys Res Commun 1987;147:196-203.
43. Grima J, Zwain I, Lockshin RA, Bardin CW, Cheng CY: Diverse secretory patterns of clusterin by epididymis and prostate/ seminal vesicles undergoing cell regression after orchidectomy. Endocrinology 1990;126:2989-2997.
44. French LE, Wohlwend A, Sappino A-P, Tschopp J, Schifferli JA: Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death. J Clin Invest 1994;93: 877-884.
45. Zhang X, Colombel M, Raffo A, Buttyan R: Enhanced expression of p53 mRNA and protein in the regressing rat ventral prostate gland. Biochem Biophys Res Commun 1994;198:1189-1194.
46. Furuya Y, Lin XS, Walsh JC, Nelson WG, Isaacs JT: Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction. Endocrinology 1995;136:1898-1906.
47. Colombel M, Radvanyi F, Blanche M, Abbou C, Buttyan R, Donehower LA, Chopin D, Thiery JP: Androgen suppressed apoptosis is modified in p53 deficient mice. Oncogene 1995;10: 1269-1274.
48. Berges RR, Furuya Y, Remington L, English HF, Jacks T, Isaacs JT: Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc Natl Acad Sci USA 1993;90: 8910-8914.
49. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LWK, Hsieh J-T, Tu S-M, Campbell ML: Expression of the protooncogene Bcl-2 in the prostate and its assocation with emergence of androgen-independent prostate cancer. Cancer Res 1992;52:6940-6944.
50. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169-1178.
51. Hakuno N, Takehiko K, Yano T, Kobayashi N, Tsutsumi O, Taketani Y, Nakane PK: Fas/APO-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia. Endocrinology 1996;137:1938-1948.
52. Turley JM, Fu T, Ruscetti FW, Mikovits JA, Bertolette DC III, Birchenall-Roberts MC: Vitamin E succinate induces fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells. Cancer Res 1997;57:881-890.
53. Truman JP, Choqueux C, Tschopp J, Vedrenne J, Le Deist F, Charron D, Mooney N: HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes. Blood 1997;89:1996-2007.
54. Ortiz-Arduan A, Danoff TM, Kalluri R, Gonzalez-Cuadrado S, Karp SL, Elkon K, Egido J, Neilson EG: Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia. Am J Physiol 1996;271:1193-1201.